New initiatives against Africa's worms
New initiatives against Africa's worms
复制标题
DOI：
10.1016/j.trstmh.2005.03.014
复制
发表时间：
2006-03-01
影响因子：
2.2
通讯作者：
Fenwick, A
中科院分区：
文献类型：
--
作者：
Fenwick, A
自1999年以来，可用于控制贫困疾病(被忽视的疾病)的资金有所增加，这主要是由于比尔和梅林达·盖茨基金会的捐款和世界银行的贷款产生的杠杆作用。由于制药公司通过垂直方案进行药品捐赠，许多国家已开始在全国范围内实施控制方案。血吸虫病控制倡议已将其业务扩大到撒哈拉以南非洲的六个国家，但不同垂直方案之间的治疗重叠现已成为现实，因此需要注意确保不会同时给予太多不同的药物。方案主管之间的对话有所增加，一些方案的整合可能提供协同增效的机会。(C)2005年皇家热带医学和卫生学会。爱思唯尔有限公司出版。保留所有权利。
Since 1999, the funding available for the control of diseases of poverty (neglected diseases) has increased mainly due to leverage resulting from donations by the Bill and Melinda Gates Foundation and loans from the World Bank. Many countries have embarked on control programmes on a national scale due to drug donations by pharmaceutical companies through vertical programmes. The Schistosomiasis Control Initiative has expanded its operations to cover six countries in sub-Saharan Africa, but overlap of treatments between different vertical programmes is now a reality, and so care is needed to ensure that too many different drugs are not given together. Dialogue between programme managers has increased, and integration of some programmes may offer chances of synergy. (c) 2005 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.